BRD-8000.3
BRD-8000.3, as a specific EfpA inhibitor, is a narrow-spectrum, bactericidal antimycobacterial agent with good wild-type activity. BRD-8000.3 can be used for the research of tuberculosis[1].
Product Specifications
CAS Number
[2365504-95-4]
UNSPSC
12352005
Target
Antibiotic
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/brd-8000-3.html
Concentration
10mM
Purity
99.65
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1C(C)(C)[C@H]1/C=C(C)\C)NC2=NC(Br)=C(C3=NC=CC=N3)C=C2
Molecular Formula
C19H21BrN4O
Molecular Weight
401.30
References & Citations
[1]Johnson EO, et al. Large-Scale Chemical-Genetic Strategy Enables the Design of Antimicrobial Combination Chemotherapy in Mycobacteria. ACS Infect Dis. 2020;6 (1) :56-63.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
244730 200 µL
CLCN7 (Chloride Channel 7, CLC-7, CLC7, FLJ26686, FLJ39644, FLJ46423, OPTA2, OPTB4)
Ask
View Details 
MBS6444564-01 0.1 mL
Apolipoprotein A-I (Apolipoprotein AI, Apo AI, Apo A-I, ApoA-I, APOA1, Apolipoprotein A1, APOA1) (MaxLight 650)
Ask
View Details MBS6444564-02 5x 0.1 mL
Apolipoprotein A-I (Apolipoprotein AI, Apo AI, Apo A-I, ApoA-I, APOA1, Apolipoprotein A1, APOA1) (MaxLight 650)
Ask
View Details 